Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.
These so many months doing FA will likely result in placing before next drilling campaign. That's the worrying bit. Silence is never a good sign! What can I say about the timing- another COBRa bite! All my gains from previously trading COBR are now gone.
TrickyDicky2(TDT)
It is the carrot indeed. We all know there is one next door, so we want it too! Do you think that Eric Sprott invested for something else? Hmm.. I think we're all after the carrot.
There is nothing positive in this RNS apart from the continued Eric Sprott support, and the very favourable financing he provides to PUR. He knows a thing or two about gold mining, and as far as I remember he invested in June last year $12mln at 90p per share. That is enough for me to hold at these levels. Sooner or later we will get to the 8th zone. They are digging towards it regardless of the low grade ore. I am certain that the AISC in the first quarter was a lot higher than $787 per ounce, but eventually it will come down as we hit the higher grade ore. New mineral resources update is due shortly. GLA
Covid trials are the only type which does require negative air pressure . Cathal has said that on the first presentation after the Whitechapel hotel deal was announced.
There is an RNS this morning on directors selling at ODX. Curious to see where their share is going to be in a month time.
On the opposite end on Friday, Directors at Ocado and Royal Mail have purchased shares in their companies on the free market, so that will be interesting to watch it too..
Looking at the current SP, I came to the conclusion that the PI's should pay very close attention to the PDMR dealings of AIM listed companies. It gives you a very good indication where the SP is going! Just look at the recent dealings, and see the results for yourself :
AVCT- Director sell on 22th Oct with the lame excuse to buy house! Price of the sell-180p, current SP=149p.
PUR-we all know the story, multiple Directors sells from $2,50 to the latest of $2,20, current SP=$2,00.
IRR-Director buy on 22th Oct at 15p, current SP=22.9p.
BOOM- multiple Directors buys between October to December at prices starting from 169p, current SP=355p.
SAA- the most recent Director buy on 04th Feb 2021 at a price of 89p, current SP just a week later of 121p.
Although the this dealings doesn't come very often, whenever they do- I will never ignore them again! Never mind what they say-to buy a house, or to pay divorce bill, etc..
Sold out today at 22% loss. For me the trial is a non-starter, as I don't think Avion will proceed without SPA. They will try to agree different protocol with FDA, but if they fail they'll just walk away. There is already approved drug in this space, so there isn't really any need for SPA from the FDA. That's the risks of investing in one trick pony. GLA
My top up of 27670 shares will probably show up as a sell. Will see in a minute.
They have used the money to pay back expensive loan. That's not the usual cash burn! There is enough money for the reminder of this year. Surely some sales will be generated before the year end.
Looks like this will be the trend until the new mineral resourses update is announced towards the end of Q1. The SP might drift even lower in February. It's clearly oversold ATM.
Bronxville, I like your view, and I have to admit that I had a same thoughts at one point. However, I think ATM Hvivo is one step away from the next level, and that is getting those Covid19 Human Challenge studies approved by MHRA. There isn't any higher levels for Hvivo other than this, and we are there because of Cathal Friel! So, you have to give the dude his due!
Verditek are cashed up for at least 12 months. They had expensive loan which has been repaid in full, so there won't be another fundraise this year. There is enough money to ramp up the production if necessary.
The sales are the weakest link here...
MHRA approval is well overdue, so I am worried. Boris Johnson's pledge for UK to become a world leader in vaccines obviously didn't persuade the MHRA to proceed accordingly. Their position probably is: 'lets wait for a cure first, which might be behind the corner'! If this is it, then we might not get it for years, and that will have an adverse impact on the rest of OO business. The wearables data will be hit hardest, no doubt about that. Uk's ambitions in the vaccine's field will be hampered. I sincerely hope that MHRA will stop this a** covering, give the approval and accept that negligible 0.03% chance of someone dying on the trials, for the wellbeing of entire humanity!
I bought £20k worth of shares yesterday at a average of 1.38, so yes there are people buying at these levels. The directors are selling, but the institutions are not! If the ii start selling then it's time to go, but I don't think for a second that this will happen. Eric Sprott is not here for a mere 50% return! Imo the SP will double in 18 months time, and that is good enough for me! GLA
I am not worried about tomorrow's RNS, as Fred Smith has no chance whatsoever. However, I am worried about an RNS in Friday next week when the option to get the remaining 3.75m from the financing deal expires. At that time the drill will have reached the first target, and BPC will have a clue what to expect next. I just can't get the logic behind that deal, why BPC asked for that option? In which circumstances they will need the extra cash? In case of discovery, or in case of duster?
UKInvestor2.0
FYI- look at the RNS from 29.09 when the first batch of 500k warrants was exercised:
total issued share capital consists of 187,769,317 Ordinary Shares.
And then the RNS from 07.12:
In conformity with DTR 5.6.1, the Company notifies that, as at the date of this announcement, it has a single class of shares in issue being ordinary shares and that, following the issue of the 5,828,211 New Shares described above, the total number of ordinary shares in issue will be 289,095,494.
This massive dilution has happened in the space of 10 weeks! 101,326,177 new shares has been issued at mostly 2p per share, so it is reasonable to expect around 2m in the bank. I think that CM should give us an update on the matter.
We got bitten by a COBRa on Christmas Eve. Not a nice feeling... It was such a pitiful attempt to hide from the fact that results were actually a duster. Not only the poor timing but also the headline ''COBR is pleased to announce significant gold intercepts at the Baggy Green deposit'' Looking back at the last CM interview on ShareTalk, when asked when the next set of results will be announced-he answered as expected-Christmas and January, and then he used the phrase ''I am certainly very excited to get those out''! He knew at that time that they were a duster... I remember that he was criticised on his previous interview for being too honest for giving a timescale for eventual success from the drilling campaign to production phase-he said 3 to 5 years is considered as success, and consequently the share price dropped. Now I'm thinking- wow ,this boy is a quick learner! He went on to say ''2021 will be a great year'! However, when he was asked about future plans he answered- ''Clarke and IOCG target at Laker, but the board will decide before New Year''. That gives me a clue that the remaining assays from Barns are at best similar to Baggy Green-i.e. another duster. Why I will stop short of selling is the COBR cash position- they should have around 2m in the bank from the warrants, and that is enough to fund another 10000 meters drilling campaign( this time I don't think Hagstrom will take equity..), without having to go to the Market. COBR will have to spend the money wisely and get the SP up before the regular placing( max 20% permitted by main market rules) later next year. At that point I may sell(depends on the POG at the time), because I wouldn't want to get bitten by a COBRa again! lol
COBR now has the money to fund another drill campaign. They will obviously focus on Clarke deposit and IOCG targets if the next set of results are similar to today's. IMO, Clarke alone has the potential to cover the Market Cap. The next fundraise is limited to 20% as per main market rules, so no need to worry too much about further dilution because next set of warrants are executable at a price of 4.5 p( if we ever get there..). 50% more from the results of this, and another whole drill campaign to go before we run out of cash. No need to panic here, just wait.
This newly renewed contract takes us to approximately 100m earnings for the 2021. 40m from fully booked Whitechapel, 40m from the Government contracts at Royal Free, and 20m from Venn. Massively undervalued business at 150m MC! Bear in mind that all those 100m are now confirmed, apart of 30m from the HCS with the Government, which are subject to Ethic committee approval. Although that this approval is very very important for a future growth, even without it we have P/E =1/2, which is still very cheap for a world leader in any field, never mind the most sought-after at present, and everybody in the world will be talking about vaccines for years to come. Nothing else is included in this valuation-wearables data, Imutex and Prep are all extras. Possible(pretty much done deal according to CF) third facility will will take us to P/E =1/1! Crazy!